WHWK · Categories · Form 4

WHWK - SEC Form 4 insider transactions

Whitehawk Therapeutics Inc. (WHWK) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for WHWK

• 13h
  SEC Form 4 filed by Director Zhao Baiteng

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 13h
  SEC Form 4 filed by Director Reeve Emma

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 13h
  SEC Form 4 filed by Director Maroun Richard E

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 13h
  SEC Form 4 filed by Director Hirmand Mohammad

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 13h
  SEC Form 4 filed by Director Desai Neil

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 13h
  SEC Form 4 filed by Director Castelein Caley

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 13h
  SEC Form 4 filed by Director Aghazadeh Behzad

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 28d
  Chief Medical Officer Dugan Margaret was granted 19,132 shares (SEC Form 4)

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 28d
  Officer Ball Bryan was granted 51,020 shares, increasing direct ownership by 13% to 448,126 units (SEC Form 4)

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 28d
  CHIEF FINANCIAL OFFICER Giacobello Scott M. was granted 38,265 shares, increasing direct ownership by 13% to 333,489 units (SEC Form 4)

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 28d
  CHIEF EXECUTIVE OFFICER Lennon David James was granted 51,021 shares, increasing direct ownership by 10% to 569,643 units (SEC Form 4)

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 28d
  Director Castelein Caley was granted 255,102 shares, increasing direct ownership by 1,295% to 274,796 units (SEC Form 4)

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 32d
  SEC Form 4 filed by Director Avoro Capital Advisors Llc

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 59d
  SEC Form 4 filed by Giacobello Scott M.

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 61d
  SEC Form 4 filed by Ball Bryan

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 63d
  SEC Form 4 filed by Ball Bryan

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 66d
  SEC Form 4 filed by Lennon David James

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 68d
  SEC Form 4 filed by Lennon David James

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 73d
  SEC Form 4 filed by Dornan David

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 73d
  SEC Form 4 filed by Dugan Margaret

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 73d
  SEC Form 4 filed by Ball Bryan

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 73d
  SEC Form 4 filed by Giacobello Scott M.

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 73d
  SEC Form 4 filed by Lennon David James

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 97d
  CHIEF FINANCIAL OFFICER Giacobello Scott M. sold $8,585 worth of shares (2,594 units at $3.31) and converted options into 6,750 shares, increasing direct ownership by 17% to 28,100 units (SEC Form 4)

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 97d
  CHIEF EXECUTIVE OFFICER Lennon David James converted options into 16,250 shares and sold $16,879 worth of shares (5,100 units at $3.31), increasing direct ownership by 33% to 44,579 units (SEC Form 4)

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 97d
  Officer Ball Bryan converted options into 5,000 shares and sold $6,070 worth of shares (1,834 units at $3.31), increasing direct ownership by 2% to 206,019 units (SEC Form 4)

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 195d
  SEC Form 4 filed by Chief Medical Officer Dugan Margaret

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 363d
  SEC Form 4 filed by Director Zhao Baiteng

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 363d
  SEC Form 4 filed by Director Desai Neil

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 364d
  SEC Form 4 filed by Director Hirmand Mohammad

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 364d
  SEC Form 4 filed by Director Maroun Richard E

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 364d
  SEC Form 4 filed by Director Reeve Emma

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 364d
  SEC Form 4 filed by Director Castelein Caley

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 364d
  SEC Form 4 filed by Director Dalal Anupam

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 364d
  SEC Form 4 filed by Director Aghazadeh Behzad

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 438d
  SEC Form 4 filed by Officer Ball Bryan

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 438d
  SEC Form 4 filed by CHIEF FINANCIAL OFFICER Giacobello Scott M.

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)
• 438d
  SEC Form 4 filed by CHIEF EXECUTIVE OFFICER Lennon David James

  4 - Whitehawk Therapeutics, Inc. (0001422142) (Issuer)

Other WHWK categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends